Abstract
Recent reports suggest that DNA methylation is involved in the cause of autoimmune disease. We investigated the alteration of DNA methylation levels in lupus strains of mice, MRL/lpr as a model, which develop an age-dependent lymphadenopathy and autoimmune disease. DNA methylation levels of thymus and axillary lymph nodes in 20-week-old MRL/lpr mice, which are in an autoimmune disease state, were lower than those of 4-week-old MRL/lpr mice with no symptoms as yet. No significant changes were observed in MRL/4- strain mice, which seemed normal at least 20 weeks, while DNA methylation levels in the spleen of both strains of mice increased significantly from the age of 4 to 20 weeks. However, no significant changes of DNA methylation levels in peripheral blood were observed with ageing in MRL strains. Moreover, we clarified that administration of 5-azacytidine had a strong effect on longer survival of MRL/lpr mice and reduced DNA methylation levels in the axillary lymph nodes and spleen. The possible relevance of DNA methylation levels to the progression of autoimmune disease is discussed.
Keywords: DNA methylation, 5-methyldeoxycytidine, 5-azacytidine, MSUMp-lpr/lpr mice, autoimmune disease
Full Text
The Full Text of this article is available as a PDF (462.6 KB).
References
- 1.Liskay RM, Evans RJ. Inactive X chromosome DNA does not function in DNA-mediated cell transformation for the hypoxanthine phosphor-ibosyltransferase gene. Proc Natl Acad Sci USA. 1980;77:4895–8. doi: 10.1073/pnas.77.8.4895. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Riggs AD. DNA methylation and late replication probably aid cell memory, and type of DNA reeling could aid chromosome folding and enhancer function. Phil Trans R Soc London B. 1990;326:285–97. doi: 10.1098/rstb.1990.0012. [DOI] [PubMed] [Google Scholar]
- 3.Molloy PL, Watt F. DNA methylation and specific protein-DNA interactions. Phil Trans R Soc London B. 1990;326:2267–75. doi: 10.1098/rstb.1990.0010. [DOI] [PubMed] [Google Scholar]
- 4.Razin A, Cedar H. DNA methylation and genomic imprinting. Cell. 1994;77:473–6. doi: 10.1016/0092-8674(94)90208-9. [DOI] [PubMed] [Google Scholar]
- 5.Cedar H. DNA methylation and gene activity. Cell. 1988;53:3–4. doi: 10.1016/0092-8674(88)90479-5. [DOI] [PubMed] [Google Scholar]
- 6.Ehrlich M, Wang RYH. 5-Methylcytosine in eukaryotic DNA. Science. 1981;212:1350–7. doi: 10.1126/science.6262918. [DOI] [PubMed] [Google Scholar]
- 7.Mazin AL. Enzymatic DNA methylation as ageing mechanism. Mol BiolMosk. 1994;28:21–51. [PubMed] [Google Scholar]
- 8.Brandeis M, Ariel M, Cedar H. Dynamics of DNA methylation during development. Bioessays. 1993;15:709–13. doi: 10.1002/bies.950151103. [DOI] [PubMed] [Google Scholar]
- 9.Rainier S, Feinberg AP. Genomic imprinting, DNA methylation, and cancer. J Natl Cancer Inst. 1994;86:753–9. doi: 10.1093/jnci/86.10.753. [DOI] [PubMed] [Google Scholar]
- 10.Corvetta A, Bitta RD, Luchetti MM, Pomponio G. 5-Methylcytosine content of DNA in blood, synovial mononuclear cells and synovial tissue from patients affected by autoimmune rheumatic diseases. J Chromatogr. 1991;566:481–91. doi: 10.1016/0378-4347(91)80265-e. [DOI] [PubMed] [Google Scholar]
- 11.Richardson BC. Effect on an inhibitor of DNA methylation on T cells. 5-Azacytidine induces self-reactivity in antigen-specific T4+ cells. Hum Immunol. 1986;17:456–70. doi: 10.1016/0198-8859(86)90304-6. [DOI] [PubMed] [Google Scholar]
- 12.Cornacchia E, Golbus J, Maybaum J, Strahler J, Hanash S, Richardson BC. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol. 1988;140:2197–200. [PubMed] [Google Scholar]
- 13.Richardson BC, Liebling MR, Hudson JL. CD4+ cells treated with DNA methylation inhibitors induce autologous B cell differentiation. Clin Immunol Immunopathol. 1990;55:368–81. doi: 10.1016/0090-1229(90)90125-a. [DOI] [PubMed] [Google Scholar]
- 14.Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ. Spontaneous murine lupus-like syndromes. J Exp Med. 1978;148:1193–215. doi: 10.1084/jem.148.5.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Nose M. Genetic basis of vasculitis in lupus mice. In: Tanabe T, editor. Intractable vasculitis syndrome. Sapporo: Hokkaido University Press; 1993. pp. 145–53. [Google Scholar]
- 16.Yoshida H, Yoshida M, Merino R, Shibata T, Izui S. 5-Azacytidine inhibits the Ipr gene-induced lymphadenopathy and acceleration of lupus-like syndrome in MRL/Mp-/pr/i!pr mice. Eur J Immunol. 1990;20:1989–93. doi: 10.1002/eji.1830200917. [DOI] [PubMed] [Google Scholar]
- 17.Maniatis T. Molecular cloning. 2. New York: Cold Spring Harbor Laboratory Press; 1982. [Google Scholar]
- 18.Gehrke CW, Mccune RA, Gama-Sosa MA, Ehrlich M, Kuo KC. Quantitative reversed-phase high-performance liquid chromatography of major and modified nucleosides in DNA. J Chromatogr. 1984;301:199–219. doi: 10.1016/s0021-9673(01)89189-5. [DOI] [PubMed] [Google Scholar]
- 19.Fukunaga RW, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992;356:314–7. doi: 10.1038/356314a0. [DOI] [PubMed] [Google Scholar]
- 20.Adachi M, Fukunaga RW, Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of Ipr mice. Proc Natl Acad Sci USA. 1993;90:1756–60. doi: 10.1073/pnas.90.5.1756. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Nagata S. Fas and Fas ligand: a death factor and its receptor. Adv Immunol. 1995;57:129–44. doi: 10.1016/s0065-2776(08)60672-0. [DOI] [PubMed] [Google Scholar]
- 22.Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol. 1985;37:269–390. doi: 10.1016/s0065-2776(08)60342-9. [DOI] [PubMed] [Google Scholar]
- 23.Nose M, Nishimura M, Kyogoku M. Analysis of granulomatous arteritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes. Am J Pathol. 1989;135:271–80. [PMC free article] [PubMed] [Google Scholar]
- 24.Zhou T, Bluethmann H, Eldridge J, Berry K, Mountz JD. Origin of CD4“CD8”B220+ T cells in USL-lprllpr mice. J Immunol. 1993;150:3651–67. [PubMed] [Google Scholar]
- 25.Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 1995;374:546–9. doi: 10.1038/374546a0. [DOI] [PubMed] [Google Scholar]
- 26.Yi AK, Klinman DM, Martin TL, Matson S, Krieg AM. Rapid immune activation by CpG motif in bacterial DNA. J Immunol. 1996;157:5394–402. [PubMed] [Google Scholar]
- 27.Wilson VL, Smith RA, Ma S, Cutler RG. Genomic 5-methyldeoxycy-tidine decreases with age. J Biol Chem. 1987;262:9948–51. [PubMed] [Google Scholar]
- 28.Schauenstein K, Csordas A, Kromer G, Dietrich H, Wick G. In-vivo treatment with 5-azacytidine causes degeneration of central lymphatic organs and induces autoimmune disease in the chicken. Int J Exp Path. 1991;72:311–31. [PMC free article] [PubMed] [Google Scholar]